Professional
Added to YB: 2024-08-07
Pitch date: 2024-06-30
NVS [bullish]
Novartis AG
+48.62%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
Market Cap
N/A
Pitch Price
CHF 102.11
Price Target
N/A
Dividend
3.11%
EV/EBITDA
N/A
P/E
N/A
EV/Sales
5.80
Sector
Pharmaceuticals
Category
growth
Show full summary:
Artisan Global Value Fund Portfolio Holding: Novartis AG
NVS: Shares +11% on strong Q1, raised outlook. Rev growth 9-10%, op profit up 11-15% for year. Double-digit Q1 rev growth, improving margins. Trades 13-14x earnings w/ healthy growth expected. Solid performer in portfolio.
Read full article (1 min)